Navigation Links
UT rheumatologists discover 2 genes related to disabling form of arthritis
Date:10/21/2007

HOUSTON (Oct. 22, 2007)Work done in part by researchers at The University of Texas Medical School at Houston has led to the discovery of two genes that cause ankylosing spondylitis, an inflammatory and potentially disabling disease. The findings are published in the Oct. 21 online edition of Nature Genetics, a journal that emphasizes research on the genetic basis for common and complex diseases.

John D. Reveille, M.D., professor and director of the Division of Rheumatology and Clinical Immunogenetics, in conjunction with Matthew A. Brown, M.D., professor of immunogenetics at Australias University of Queensland, led research done by the Triple A Spondylitis Consortium Genetic Study (i.e. the TASC or Australo-Anglo-American Spondylitis Consortium).

The international team of researchers worked with investigators from the British Wellcome Trust Case Control Consortium, and together they made the genetic discovery.

Reveille, chief of rheumatology at Memorial Hermann Texas Medical Center, said the discovery of genes ARTS1 and IL23R brings the scientific community two steps closer to fully understanding ankylosing spondylitis or AS, a chronic form of arthritis that attacks the spine and also can target other joints and organs in the body.

Weve long known that the HLA-B27 gene accounts for 40 percent of the overall cause of AS, said Reveille, the principal investigator of TASC. Now we have found two new genes. Together with HLA-B27, these genes account for roughly 70 percent of the overall cause. That means weve almost nailed this disease. Within the next year, I predict we will have identified all the genes that play a role in this insidious disease. There is more exciting news to come.

The recent discovery is based on work from the largest and most comprehensive genome-wide association scan conducted to date. In this part of the research project, investigators were searching for genetic information related to AS, as w
'/>"/>

Contact: Meredith Raine
Meredith.Raine@uth.tmc.edu
713-500-3030
University of Texas Health Science Center at Houston
Source:Eurekalert

0

GOOD

Page: 1 2 3

Related medicine news :

1. Rheumatologists Underestimate the Patients Ability to Work
2. PRIMARY PULMONARY HYPERTENSION GENE DISCOVERED
3. New Way to "See" Genes, Evaluate Effectiveness of Gene Therapies Discovered
4. OHSU Researchers Announce New Discovery
5. Poisonous Parkinsons molecule discovered
6. Discovery of bone gene
7. Genes for Vision discovered
8. Chemists Discover Cation Considered Too Unstable To Exist
9. New breast cancer genes discovered
10. Latest discovery on Autism
11. Bacterial discovery may help CF patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2008)... As the International Day ... Ships celebrates with the story of a young boy bo...ies onboard the Africa Mercy, a floating hospital ...ow and he can run and play with the other children...e downloaded at www.mercyshipsnewsroom.org , ...
(Date:12/2/2008)... Orion Health announces th... (SEARHC) of Juneau, Alaska, has selected the Rhap...nt electronic health record, radiology, pharmacy, ...each other. It also plans to extend connectivity t...Alaska immunization registry) and AKAIMS (an MIS a...
(Date:12/2/2008)...ARIS, Dec. 2 Motorola, I...plemented its T2 powerbroadband system to enable,...e healthcare provider,Generale de Sante to deliv...,Motorola solution provides an advanced IP broadba...delivered over the existing telephone line, elimin...
(Date:12/1/2008)...OUTH BEND, Ind., Dec. 2 Patient sa...ities are on the rise according to a new report,f...ent Pulse Report: Patient,Perspectives on America...acilities as a driver for improvement in patient s... than 2 million patients treated at more than,1,2...
Breaking Medicine News(10 mins):Health News:Mercy Ships Recognizes International Day of Disabled Persons 2Health News:Mercy Ships Recognizes International Day of Disabled Persons 3Health News:SouthEast Alaska Regional Health Consortium Selects Orion Health's Rhapsody Integration Engine for Full-scale Application Integration and Monitoring 2Health News:SouthEast Alaska Regional Health Consortium Selects Orion Health's Rhapsody Integration Engine for Full-scale Application Integration and Monitoring 3Health News:Motorola Extends the Delivery of Personalized Media Experiences to Hospital Group Generale De Sante 2Health News:Motorola Extends the Delivery of Personalized Media Experiences to Hospital Group Generale De Sante 3Health News:Outpatient Service Facilities Face Increasing Competition - Patient Perceptions More Important Than Ever 2
...es Inc. today announced that Mylan Pharmaceuticals.... Food and Drug Administration (FDA) for its Abbr... Hydrochloride Extended-release Tablets, 12.5 mg a...o receive final approval on June 29, 2007, concurr...
...report released today documents the explosive grow...t more than 200 million people are now protected b...nd public places. The report concludes that the mo...accelerating because a global treaty ratified by 1...
...Technologies, Inc. (NTI) announced today the prese...l trials of ancrod and updates on the clinical de...TM) (ancrod), for the treatment of acute ischaemic...ss in Glasgow, Scotland in the United Kingdom. Vip...
... the number two killer in our nation, Americans ar...n fact, according to a recent nationwide survey sp... the scientific community is winning the war again...arching new options to fight cancer, Abbott is ho...
Other Medicine News:Health News:Growth of Smoke-Free Air Laws Worldwide; More Than 200 Million Found "Fully Protected" 2Health News:Investigational Drug Being Pursued for the Treatment of Ischaemic Stroke 2Health News:Americans Optimistic About the War on Cancer 2
(Date:11/26/2008)... , FRANKLIN, Mass., Nov. 26 /PRNewswire-Firs...CSF) announced today that it has received full app...FDA) for its U.S. pivotal trial to study the effec...nd associated therapy in the prevention of Contras...so approved PLC,s request to expand their investig...
(Date:11/25/2008)...ire-USNewswire/ -- Kleinert Kutz and University o...S. hand transplant on Messina, New York resident, ...al Hand Care Center on Monday, November 24. The i...leted shortly after 9 p.m. in a record nine hours....in/prnh/20081125/DC48555-a ) , (Photo: http:/...
(Date:11/25/2008)... 25 Proteolix, Inc., a,leader in ...s that target,protein degradation pathways in can... data from two ongoing Phase 2 clinical trials of ... at the upcoming 50th Annual Meeting of the,Ameri...he first in a new class,of specific proteasome in...
(Date:11/25/2008)...swire-FirstCall/ -- Pharmacyclics, Inc.,(Nasdaq: ...leted a Phase 1,clinical trial with PCI-27483, th...Factor VIIa inhibitor. The trial was conducted in ...afety and pharmacologic effect of,PCI-27483. A si...ear dose,response in the International Normalized...
Breaking Medicine Technology:PLC Systems Receives Full FDA Approval for Pivotal Study of RenalGuard(TM) in The U.S. 2PLC Systems Receives Full FDA Approval for Pivotal Study of RenalGuard(TM) in The U.S. 3PLC Systems Receives Full FDA Approval for Pivotal Study of RenalGuard(TM) in The U.S. 4Kleinert Kutz Hand Surgeons Perform Fifth U.S. Hand Transplant in Record Time at Jewish Hospital Hand Care Center 2Kleinert Kutz Hand Surgeons Perform Fifth U.S. Hand Transplant in Record Time at Jewish Hospital Hand Care Center 3Proteolix to Present Clinical and Preclinical Data at the 50th Annual Meeting of the American Society of Hematology 2Proteolix to Present Clinical and Preclinical Data at the 50th Annual Meeting of the American Society of Hematology 3Pharmacyclics Announces Completion of Phase 1 Clinical Trial of Factor VIIa Inhibitor PCI-27483 2Pharmacyclics Announces Completion of Phase 1 Clinical Trial of Factor VIIa Inhibitor PCI-27483 3Pharmacyclics Announces Completion of Phase 1 Clinical Trial of Factor VIIa Inhibitor PCI-27483 4Siemens Soarian Health Information Management is Widely Adopted by Leading Healthcare Institutions in 2007 3089 1Siemens Soarian Health Information Management is Widely Adopted by Leading Healthcare Institutions in 2007 3089 2Siemens Soarian Health Information Management is Widely Adopted by Leading Healthcare Institutions in 2007 3089 3Siemens Soarian Health Information Management is Widely Adopted by Leading Healthcare Institutions in 2007 3089 4Consumer Safety Alert on Fat Dissolving Injections 3086 1Consumer Safety Alert on Fat Dissolving Injections 3086 2Consumer Safety Alert on Fat Dissolving Injections 3086 3N V Perricone M D Cosmeceuticals Elevates Role of Christina Banas to Executive Director Global Communications 3083 1N V Perricone M D Cosmeceuticals Elevates Role of Christina Banas to Executive Director Global Communications 3083 2Anaptys Biosciences Appoints R Scott Greer to Board of Directors 1119 1Anaptys Biosciences Appoints R Scott Greer to Board of Directors 1119 2
...-May 10, 2007 - According to,The Waismann Method 2...respondents seeking treatment for opiate dependenc...icodin, OxyContin, Percocet,and Fentanyl were amon...mothers who reported a dependency said they suffer...egistered addiction,specialist for the Waismann Me...
...oping Therapies to Prevent,and Reverse Atheroscler...07 /PRNewswire/ -- KineMed, Inc.,a pathway-based ...today the first method for measuring the efflux of...athway known as reverse cholesterol,transport (RCT...,cholesterol can be removed from tissues and has t...
Other Medicine Technology:Waismann Method Survey Reveals 65 Percent of Women Seeking Opiate,Dependency Treatment Are Mothers 2KineMed Presents Data Measuring Changes in Reverse Cholesterol,Transport for the First Time 2KineMed Presents Data Measuring Changes in Reverse Cholesterol,Transport for the First Time 3
Set of 5 large bone curettes. One each of the following: angled small, straight small, angled medium, straight medium, and angled large.
Rasp with down cutting pattern.
Designed for proximal femoral elevation in total hip replacement or in other surgery with a similar need for bone manipulation.
Beuse Zygomatic Arch Awl with slightly curved tip.
Medicine Products: